XHSvsXBIETF Comparison
VS
State Street SPDR S&P Health Care Services ETF (XHS) and State Street SPDR S&P Biotech ETF (XBI) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. Both XHS and XBI have the same Total Expense Ratio (TER) of 0.35%. XHS is up 14.1% year-to-date (YTD) with +$13M in YTD flows. XBI performs worse with 9.68% YTD performance, and -$269M in YTD flows. Run a side-by-side ETF comparison of XHS and XBI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XHS vs XBI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 06/12/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XHS XBI | +7.30%-0.89% | +18.28%+9.09% | +14.10%+9.68% | +25.29%+59.15% | +34.73%+51.71% | +7.94%-1.65% |
| Flows | XHS XBI | +$1M-$91M | +$8M-$210M | +$13M-$269M | +$79K+$444M | -$23M-$1.14B | -$74M+$810M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XHS XBI | +16.63%+32.47% | +17.99%+26.10% | +17.97%+27.60% | +21.22%+32.77% |
| Max drawdown | XHS XBI | -5.61%-8.56% | -11.97%-9.66% | -17.78%-32.94% | -32.53%-54.69% |
| Max drawdown duration | XHS XBI | 21d54d | 121d76d | 362d331d | 1786d1754d |
Trading data
XHS | XBI | |
Last sale 6/12/2026 at 1:30 PM | $122.08 | $133.79 |
| Previous close 06/11/2026 | $121.70 | $132.74 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of May 29, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XHS | XBI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 6/12/2026 at 1:30 PM
Live
Closed
XHS | XBI | |
|---|---|---|
| Last price | $122.08 | $133.79 |
| 1D performance | +0.31% | +0.79% |
| AuM | $109.72 M | $8.30 B |
| E/R | 0.35% | 0.35% |
Characteristics
XHS | XBI | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | State Street Investment Management | State Street Investment Management |
| Benchmark | S&P Health Care Services Select Industry Index | S&P Biotechnology Select Industry Index |
| N° of holdings | 51 | 119 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 28, 2011 | January 31, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
XHS
USA
99.91%
Other
0.09%
XBI
USA
94.81%
Other
5.19%
Sectors
XHS
Health Care
86.95%
Other
13.05%
XBI
Health Care
85.15%
Other
14.85%
Advertisement
Diversification
XHS
Total weight of top 15 holdings out of 15
33.75%
XBI
Total weight of top 15 holdings out of 15
20.97%
Top 15 holdings
Data as of April 30, 2026
XHS
CENTENE
2.76%
HUMANA
2.55%
MOLINA HLTHCRE
2.44%
ELEVANCE HEALTH INC
2.39%
UNITEDHEALTH GRP
2.39%
ALIGNMENT HEALTHCARE
2.31%
CLOVER HEALTH INV CORP
2.28%
APOLLO MEDICAL HOLDINGS INC
2.25%
US10950A1060
2.14%
MEDNAX
2.10%
PRIVIA HEALTH GROUP
2.07%
CIGNA
2.05%
CVS HEALTH CORP
2.03%
CORVEL
2.00%
ACADIA HEALTHCARE COMPANY
2.00%
XBI
APELLIS PHARMACEUTICALS
1.87%
REVOLUTION MEDICINES INC
1.65%
TRAVERE THERAPEUTICS INC
1.62%
ARROWHEAD PHARMACEUTICALS INC
1.44%
TWIST BIOSCIENCE CORP
1.42%
US86627T1088
1.40%
ALKERMES
1.38%
TG THERAPEUTICS
1.37%
MADRIGAL PHARMACEUTICALS INC
1.36%
BEAM THERAPEUTICS
1.32%
US03770N1019
1.26%
SCHOLAR ROCK HOLDING CORP
1.23%
US74006W2070
1.22%
EXELIXIS
1.21%
MIRUM PHARMACEUTICALS INC
1.21%
Frequently asked questions about XHS and XBI
How have the XHS and XBI ETFs performed in 2026?
As of June 12, 2026, XHS is up 14.1% year-to-date (YTD), while XBI has returned 9.68%. That puts XHS better performer ahead so far this year.
Which ETF is attracting more investor money: XHS or XBI?
Year-to-date, the XHS ETF saw +$13M in flows, compared to -$269M for XBI.
Which ETF is more volatile: XHS or XBI?
Over the past year, XHS had a volatility of 17.99%, while XBI experienced 26.1%.
Which ETF is bigger: XHS or XBI?
As of June 12, 2026, XHS holds $109.72 M in assets under management (AUM), while XBI manages $8.30 B.
What sectors do the XHS and XBI ETFs invest in?
XHS leans toward sectors like Health Care. Meanwhile, XBI focuses on Health Care.
What are the top holdings of the XHS ETF and XBI ETF?
XHS top holdings include CENTENE, HUMANA and MOLINA HLTHCRE. XBI holds in its top three: APELLIS PHARMACEUTICALS, REVOLUTION MEDICINES INC and TRAVERE THERAPEUTICS INC.
Which ETF is more diversified: XHS or XBI?
XHS holds 58 securities with 33.75% of its assets in the top 15. XBI has 148 securities and a top 15 weight of 20.97%.
Advertisement
Latest news about XHS & XBI
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
September 18, 2025
XBI
Are Biotechnology ETFs In the Midst of a Comeback?
August 20, 2025
XBI
Two biotech ETFs to watch for the rest of 2022 and beyond
September 13, 2022
XBI
Biotech ETFs – Investing in Health Innovation
July 21, 2022
XBI
Advertisement
Advertisement
